@article{9702d5dd670d4eb1b0769d83b74faf6e,
title = "Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma",
keywords = "mTOR-inhibitor, Everolimus, Pneumonitis, NONINFECTIOUS PNEUMONITIS, NEUROENDOCRINE TUMORS, PULMONARY TOXICITY, MTOR INHIBITORS, PHASE-3 TRIAL, OPEN-LABEL, CANCER, MANAGEMENT, THERAPY, BIOMARKERS, 3122 Cancers",
author = "P. Penttila and F. Donskov and J. Rautiola and K. Peltola and M. Laukka and P. Bono",
year = "2017",
month = aug,
doi = "10.1016/j.ejca.2017.05.004",
language = "English",
volume = "81",
pages = "9--16",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER SCI IRELAND LTD",
}